## MO: Altria Group, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 1.3% below STRENGTH zone (4.0-10.0%); PEG 4.01 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($57.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. 1 Stock I'd Buy Before Altria (MO) In 2026**
- Source: Finviz | 20251215T210932 | Neutral | Relevance: 100%
- This article compares Altria (MO) and Coca-Cola (KO) as long-term investment options, ultimately recommending Coca-Cola. While Altria offers a high dividend yield and low valuation, Coca-Cola is presented as a more diversified company with stronger growth, a simpler business model, and more stable long-term prospects. Coca-Cola's Dividend King status and expected outperformance in a market rotating to evergreen dividend stocks also make it a better choice.

**2. Altria names new CEO**
- Source: C-Store Dive | 20251215T150832 | Neutral | Relevance: 100%
- Altria Group has announced that CEO Billy Gifford will retire on May 14, 2026, and Salvatore Mancuso will succeed him. Mancuso, currently Altria's Executive Vice President and CFO, has a three-decade career with the company in various finance roles. Heather Newman will take over Mancuso’s CFO position after the transition.

**3. Altria Group (MO): Navigating a Smoke-Free Future – A Comprehensive Stock Analysis**
- Source: Markets Financial Content | 20251215T102100 | Neutral | Relevance: 100%
- Altria Group (MO) is currently navigating a transition from traditional tobacco products to smoke-free alternatives, with its stock performance driven by robust dividends despite declining cigarette consumption. The company aims for over half of its revenue to come from smoke-free products by 2030, investing heavily in oral nicotine pouches like "on!" and e-vapor products like NJOY. Altria faces challenges from regulatory scrutiny and intense competition in the RRP market, but its strong financial position and strategic pivots offer potential for long-term growth and continued shareholder returns.

**4. 27,520 Shares in Altria Group, Inc. $MO Acquired by Caldwell Trust Co**
- Source: MarketBeat | 20251215T100021 | Somewhat-Bullish | Relevance: 100%
- Caldwell Trust Co. recently acquired 27,520 shares of Altria Group (MO), valued at approximately $1.613 million, amidst increased institutional holdings by several other major investors. Altria's board authorized a $2.00 billion share repurchase program and declared a quarterly dividend of $1.06, providing a 7.2% yield. Shares are currently trading around $58.76, with a "Hold" consensus rating from analysts and a target price of $62.33.

**5. Texas Permanent School Fund Corp Lowers Stake in Altria Group, Inc. $MO**
- Source: MarketBeat | 20251216T124342 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Altria Group Inc. (NYSE:MO) by 26.5% during Q2, selling 48,875 shares and leaving it with 135,396 shares valued at approximately $7.94 million. Concurrently, Altria announced a quarterly dividend of $1.06 (7.2% yield) and a $2.0 billion share repurchase program. Analyst opinions vary, with a "Hold" consensus rating and a target price of $62.33, alongside mixed individual firm price target adjustments.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (-0.4%)
- Blackrock Inc.: 7.5% (+2.4%)
- State Street Corpora: 4.3% (-0.9%)
- Charles Schwab Inves: 3.5% (-4.7%)
- Geode Capital Manage: 2.7% (+1.2%)

### Key Risks

1. Valuation stretched: PEG 4.0x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +3.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.01 signals overvaluation risk, limited margin of safety. Forward P/E 10.6x stretched relative to 3% growth. Quality metrics strong (ROA 22%, margin 44%). Balance sheet: $3.4B free cash flow. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $99.3B |
| Beta | 0.50 |
| 52W Range | $50.08 - $68.60 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.01 |
| Forward P/E | 10.6 |
| Current P/E | 10.9 |
| YoY Growth | 2.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.4% to 1.3% (+3.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.7pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 51. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.27% (CS: 47) | Neutral |
| RSI_14 | 51.1 | Neutral |
| MACD Histogram | 0.24 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 0.977x | Below |
| vs SMA200 | 0.974x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $59.09
- **Stop Loss:** $57.39 (2.9% risk)
- **Target:** $60.79 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 705
- **Position Value:** $41,658.45
- **Portfolio %:** 41.66%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.45 | $1.45 | +0.1% |
| 2025Q2 | $1.38 | $1.44 | +4.0% |
| 2025Q1 | $1.19 | $1.23 | +3.5% |
| 2024Q4 | $1.28 | $1.29 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*